ICD-10-CM Billable Code

T37.3X5

Adverse effect of other antiprotozoal drugs

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code T37.3X5 refers to adverse effects caused by antiprotozoal drugs that are not specified in other categories. These medications are used to treat protozoal infections, but like all drugs, they can sometimes cause unexpected side effects. Recognizing these adverse reactions is important for patient safety and effective management.

Causes & Symptoms

Clinical Causes: Use of specific antiprotozoal medications such as metronidazole, tinidazole, or others prescribed for protozoal infections. Overdose or extended use of antiprotozoal drugs beyond recommended durations. Allergic reactions to components of the medication. Interactions with other medications that may enhance toxicity or side effects. Individual patient sensitivities or predispositions to drug reactions.

Key Symptoms: Gastrointestinal disturbances such as nausea, vomiting, diarrhea, or abdominal pain. Neurological symptoms including dizziness, headache, or peripheral neuropathy. Skin reactions like rash, itching, or urticaria. Liver enzyme abnormalities indicating hepatic stress or damage. Hematological effects such as leukopenia or anemia. General malaise or fatigue.

Diagnostic & Treatment

Diagnosis Path: Diagnosis primarily involves reviewing the patient's medication history and clinical presentation. Healthcare providers may perform blood tests to identify liver function abnormalities, blood cell counts, or allergic reactions. Differentiating between adverse drug reactions and other medical conditions is crucial for proper management.

Treatment Protocols: Management includes discontinuing or adjusting the use of the offending medication. Supportive care depends on the severity and type of adverse effects, possibly involving symptomatic relief for symptoms like nausea or rash. In cases of serious reactions, medical intervention may include corticosteroids or other specific therapies. Monitoring for recovery and preventing further adverse effects are integral parts of patient care.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T37.3X5 a billable ICD-10 code?
Yes, T37.3X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T37.3X5?
Clinical documentation must specify the nature of Adverse effect of other antiprotozoal drugs and any associated comorbidities for accurate reporting.

Cite this Clinical Reference